Navigation Links
Transgenomic, Inc. Reports Fourth Quarter and Fiscal Year 2008 Results
Date:3/18/2009

million for the year ended December 31, 2007. Gross profit from continuing operations was $13.6 million or 57 percent for the year ended December 31, 2008 compared to $12.7 million or 55 percent for the year ended December 31, 2007. Operating expenses from continuing operations were $14.0 million for the year ended December 31, 2008 which included a $638,000 goodwill impairment and income from foreign currency revaluation of $1.0 million. Operating expenses from continuing operations for the year ended December 31, 2007 were $16.0 million, which included $1.5 million in restructuring charges for the year ended December 31, 2007. The Company used cash flows in operations of $413,000 for the year ended December 31, 2008 compared to cash flows used in operations of $2.9 million for the year ended December 31, 2007.

Comment and Outlook

Craig Tuttle, the Company's President and Chief Executive Officer, noted, "We are quite pleased with the overall results of the year. Our Molecular Reference Lab grew 70% in the year and we continued to make gains in our Pharmacogenomics services business by adding several key new pharma customers. With this growth in our services business, our previous significant effort in cost reduction and investment in our sales organization, we have achieved close to breakeven performance for the year."

"We continued to improve our operations efforts for our Molecular Reference Laboratory business as well as our WAVE system and reagent manufacturing activities. These efforts resulted in our lab gaining accreditation by the College of American Pathologists (CAP) and our manufacturing site attaining ISO9001:2000 accreditation during the fourth quarter."

"Most importantly, we embarked on an aggressive pursuit of new assay technology to drive both short and long-term growth for our laboratory businesses. Key licensing efforts during the year included our exclusive licenses with the
'/>"/>

SOURCE Transgenomic, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Transgenomic, Inc. Reports Second Quarter 2007 Results
2. Transgenomic, Inc. Forms Scientific Advisory Board
3. Transgenomic, Inc. Reports Third Quarter 2008 Results
4. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
5. QMed, Inc. Reports July Medicare SNP Enrollments
6. Phlo Affiliate Reports Expanded Coverage to Oregon Border
7. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
8. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
9. Carrington Reports Second Quarter 2007 Results
10. Avitar Reports Third Quarter Financial Results for Fiscal 2007
11. Response Genetics Reports Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... July 30, 2014  The Chicago Bears are excited ... of Dermatology (Academy) in an effort to raise awareness ... will host free SPOT me™ skin cancer screenings at ... Soldier Field. SPOT me™ is an educational campaign ... dangers and risks of skin cancer, and encourages people ...
(Date:7/30/2014)... 2014 Sales Horizons, a leader in ... sales training programs for companies engaged in complex B2B ... by thousands of salespeople over 25 years in market-leading ... can be customized to address the unique sales challenges ... sales training program consists of two parts: Mastering ...
(Date:7/30/2014)... BCC Research ( http://www.bccresearch.com ) reveals in ... Industrial Applications , the global market for industrial enzymes ... 2018, registering a five-year compound annual growth rate (CAGR) ... in the detergent enzyme segment with a CAGR of ... influenced almost every sector of industrial activity, ranging from ...
(Date:7/30/2014)... July 30, 2014  Dyadic International, Inc. ("Dyadic") ... patented and proprietary technologies are used to discover, ... for the bioenergy, bio-based chemical, biopharmaceutical and industrial ... "Tom" Dubinski as Vice President and Chief Financial ... financial and information technology operations for Dyadic and ...
Breaking Biology Technology:Chicago Bears Join the American Academy of Dermatology in Fight against Skin Cancer 2Chicago Bears Join the American Academy of Dermatology in Fight against Skin Cancer 3Chicago Bears Join the American Academy of Dermatology in Fight against Skin Cancer 4Sales Horizons Launches New Blended Sales Training Programs to Companies Engaged in Complex B2B Sales 2Sales Horizons Launches New Blended Sales Training Programs to Companies Engaged in Complex B2B Sales 3Global Market for Industrial Enzymes to Reach Nearly $7.1 Billion by 2018; Detergent Enzyme Market to Record Maximum Growth 2Global Market for Industrial Enzymes to Reach Nearly $7.1 Billion by 2018; Detergent Enzyme Market to Record Maximum Growth 3Thomas Dubinski joins Dyadic as Chief Financial Officer 2Thomas Dubinski joins Dyadic as Chief Financial Officer 3Thomas Dubinski joins Dyadic as Chief Financial Officer 4
... DiObex, Inc., a privately held,biotechnology company focused on the ... CEO David Cory will deliver a,corporate presentation at the ... Medical Device Conference in New York,New York. The DiObex ... a.m. at the Grand Hyatt Hotel in the Broadway ...
... Echo Therapeutics,Inc. (OTC Bulletin Board: ECTE), a ... Patrick T. Mooney, M.D, Chairman,and Chief Executive Officer, ... February 7, 2008 at 3:50 pm Mountain Standard ... be held at the Four Seasons,Resort in Scottsdale, ...
... plc,(LSE:EHP) announced today that it had successfully completed ... its proprietary, minimally invasive,plucked human hair biomarker technology ... analysing gene expression change in,RNA extracted from the ... a single human,plucked hair. Changes in gene expression ...
Cached Biology Technology:Echo Therapeutics to Present at RedChip Small-Cap Investor Conference 2Epistem plc and AstraZeneca Complete Plucked Hair Biomarker Study for Oncology Drug Development 2Epistem plc and AstraZeneca Complete Plucked Hair Biomarker Study for Oncology Drug Development 3Epistem plc and AstraZeneca Complete Plucked Hair Biomarker Study for Oncology Drug Development 4
(Date:7/30/2014)... unveiled the first high-resolution map of the carbon ... of Per. The new and improved methodology used ... for future market-based carbon economies. The new ... diversity and it provides the critical input to ... land use, and enforcement purposes. The technique includes ...
(Date:7/29/2014)... BELLINGHAM, Washington, USA The advanced optical methods and ... are driving a revolution in the neurosciences were the ... published by SPIE, the international society for optics and ... of the BRAIN Initiative in the United States, and ... vision for and provide examples of the impact that ...
(Date:7/29/2014)... ever ordered the wrong food at a restaurant, don,t blame ... less to do with what you want and more to ... 217 menus and the selections of over 300 diners, the ... of Hospitality Management showed that when it comes to ... you see on the menu and how you imagine it ...
Breaking Biology News(10 mins):Peru's carbon quantified: Economic and conservation boon 2Peru's carbon quantified: Economic and conservation boon 3SPIE launches Neurophotonics journal with special section on BRAIN Initiative 2SPIE launches Neurophotonics journal with special section on BRAIN Initiative 3Menu secrets that can make you slim by design 2
... insects and fish have evolved camouflage defences to deter attack ... has discovered that trees in New Zealand have evolved ... providing the first evidence of this strategy in plant life. ... herbivores and in response they have evolved a variety of ...
... , , CHICAGO, July ... Perception Research Services International (PRS) and EmSense Corporation announced their ... The companies presented findings from a recent joint study, ... unit to link package viewing patterns with measures of cognition ...
... 2009 Schizophrenia is a severely debilitating psychiatric disease ... development of the nervous system; however, major breakthroughs linking ... unrealized. Jill Morris, PhD assistant professor of Pediatrics at ... in the Human Molecular Genetics Program of Children,s Memorial ...
Cached Biology News:New discovery suggests trees evolved camouflage defense against long extinct predator 2PRS And EmSense Partner To Integrate Bio-Sensory Measures In Packaging Research Studies 2A genetic basis for schizophrenia 2
For the differentiation of mouse embryonic stem cells tooligodendrocytes....
Preadipocyte factor-1 [Pref-1, DLK-1], C-terminal...
IC50: 35 ng/ml · Limit of detection: 8 ng/ml...
, Glycerol 30%...
Biology Products: